Division of Nuclear Medicine (Medical University of Vienna)

What Division of Nuclear Medicine (Medical University of Vienna) does

The Division of Nuclear Medicine (Klinische Abteilung für Nuklearmedizin) is one of four specialized clinical divisions within the Universitätsklinik für Radiologie und Nuklearmedizin, the University Clinic for Radiology and Nuclear Medicine at the Medical University of Vienna (Medizinische Universität Wien), operating within the Universitätsklinikum AKH Wien (General Hospital of Vienna). The division delivers nuclear medicine diagnostic and therapeutic services — including high-resolution imaging and image-guided therapies — to inpatients and outpatients of AKH Wien, patients referred from Austrian federal states, and patients referred from neighboring countries. The clinic is described as one of the largest and most powerful radiology and nuclear medicine clinics in Europe, with the four divisions addressing general/pediatric radiology, cardiovascular and interventional radiology, neuroradiology and musculoskeletal radiology, and nuclear medicine.

Co-located with the clinical divisions are three specialized research facilities: the CIR Computational Imaging Research Lab, the HFMRC High Field Magnetic Resonance Center, and the Preclinical Imaging Laboratories (PIL). These provide translational infrastructure covering computational imaging, high-field MRI, and preclinical pipelines. The clinic also runs structured medical education and continuing professional development (including the recurring Al4Imaging Summer School, radiation protection training, and observer/fellow programs) and maintains a referring-physician orientation guide for the regional radiology referral network.

The division is a public-law entity within the Austrian state university and hospital system, headed by Univ.-Prof.in Dr.in Ulrike Attenberger as clinic director, with Prof. Christian Loewe as head of the Cardiovascular and Interventional Radiology division following his appointment in August 2025. It is not a commercial enterprise: revenue flows through the Austrian public healthcare funding framework rather than priced commercial contracts, no equity exists, and GTM is executed through institutional referral networks, academic publishing, and medical education rather than commercial sales channels. The firmographic record lists 10 employees, which appears to be a sub-segment rather than the full division headcount.

Name

Division of Nuclear Medicine (Medical University of Vienna)

Legal name

Universitätsklinik für Radiologie und Nuklearmedizin, Medizinische Universität Wien

Website

https://radnuk.meduniwien.ac.at

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

The Division of Nuclear Medicine is a public university hospital department within MedUni Wien and AKH Wien, delivering nuclear medicine diagnostics and image-guided therapies to inpatients at AKH Wien and patients referred from Austrian federal states and neighboring countries.

Ownership category

akta.pro rank

Product category

Nuclear Medicine Services

NAICS

Diagnostic Imaging Centers (621512)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)

akta.pro primary industry

Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI)

akta.pro secondary industry

Therapeutic Radiopharmaceuticals (Radioligand/Targeted Radionuclide Therapy) (HLAIAGAB)

Keywords

• Nuclear medicine services
• Medical imaging diagnostics
• Image-guided therapy
• University hospital radiology
• Molecular imaging research

Headquarters

HQ city

Vienna

HQ country

Austria

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Distribution channels3 records

Marketing channels4 records

Core offering

The Division of Nuclear Medicine is one of four specialized clinical departments within the Universitätsklinik für Radiologie und Nuklearmedizin at MedUni Wien, delivering nuclear medicine diagnostic and therapeutic services. It supports inpatient and outpatient care at Universitätsklinikum AKH Wien and accepts referrals from Austrian federal states and neighboring countries, combining clinical service with research activities housed in the CIR, HFMRC, and PIL labs.

Product overview

The Universitätsklinik für Radiologie und Nuklearmedizin is a medical clinic providing modern imaging diagnostics and image-guided therapies at four specialized clinical departments. The Division of Nuclear Medicine is one of these departments, offering nuclear medicine services. This is a clinical healthcare institution, not a technology product company. The clinic operates research labs including CIR (Computational Imaging Research), HFMRC (High Field Magnetic Resonance Center), and PIL (Preclinical Imaging Laboratories).

Differentiator

Problem solved

Functional benefit

Products and services

• Klinische Abteilung f\u00fcr Nuklearmedizin (Clinical Division of Nuclear Medicine) Clinical department providing nuclear medicine diagnostic and therapeutic services to patients of Universit\u00e4tsklinikum AKH Wien and to referrals from Austrian federal states and neighboring countries.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin: One of Europe's largest university hospital nuclear medicine departments operating within a major German university hospital. Directly comparable as a European academic nuclear medicine center offering diagnostic imaging and radionuclide therapy, with comparable research lab infrastructure.
• Department of Nuclear Medicine, University Hospitals Leuven: Belgian university hospital nuclear medicine department with strong research output. Comparable in scale, academic mission, and proximity to the broader Austrian/Central European patient catchment.
• Department of Nuclear Medicine, Pitié-Salpêtrière Hospital (AP-HP): Large French university hospital nuclear medicine department within a leading European academic medical center. Comparable in clinical volume, specialty breadth, and integration with public hospital funding structures.
• Department of Nuclear Medicine, University Hospital Zurich: University hospital nuclear medicine department serving a German-speaking European catchment with combined diagnostic imaging and therapy services. Highly comparable in scale, academic mission, and integration with a major university hospital.
• Department of Nuclear Medicine, Heidelberg University Hospital: Major German university hospital nuclear medicine department known for theranostics and oncology-focused radionuclide therapy. Comparable in academic standing, theranostics capability, and integration with translational research institutes.
• Department of Nuclear Medicine, Karolinska University Hospital: Nordic academic nuclear medicine department within a leading European university hospital. Comparable in clinical-research mix, residency/fellowship training programs, and exposure to international patient referrals.
• Department of Nuclear Medicine, Erasmus MC: Major Dutch academic hospital nuclear medicine department. Comparable as a European university nuclear medicine center with combined imaging, therapy, and translational research programs.
• Department of Nuclear Medicine, Rigshospitalet (Copenhagen): Nordic university hospital nuclear medicine department serving as a tertiary referral center. Comparable in clinical-academic integration and in operating under a publicly funded European healthcare system.
• Department of Nuclear Medicine, University Hospital Munich (LMU/TUM): Large German university hospital nuclear medicine service with strong research and theranostics offerings. Comparable in academic profile, equipment base, and DACH-region patient catchment overlap with Vienna.

Emerging players

• School of Biomedical Engineering & Imaging Sciences, King's College London: UK-based academic imaging research and clinical nuclear medicine partnership (Guy's and St Thomas'). Comparable as an academic imaging research hub integrating computational imaging with nuclear medicine practice, though with a more research-oriented structure than Vienna's clinical division.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/division-of-nuclear-medicine-muv

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Division of Nuclear Medicine (Medical University of Vienna)